Results 11 to 20 of about 274 (96)

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)

Journal of Translational Medicine, 2023
Outcomes for patients with melanoma have improved over the past decade with the clinical development and approval of immunotherapies targeting immune checkpoint receptors such as programmed death-1 (PD-1), programmed death ligand 1 (PD-L1) or cytotoxic T
P. Ascierto, S. Agarwala, A. B. Warner, M. Ernstoff, B. Fox, T. Gajewski, J. Galon, C. Garbe, B. Gastman, J. Gershenwald, P. Kalinski, M. Krogsgaard, R. Leidner, R. Lo, A. Menzies, O. Michielin, Poulikos I. Poulikakos, J. Weber, C. Caracò, I. Osman, I. Puzanov, M. Thurin   +21 more
semanticscholar   +1 more source

ASH highlights 2022—multiple myeloma

memo - Magazine of European Medical Oncology, 2023
The 64th annual meeting was held in New Orleans, Louisiana from December 10–13, 2022. More than 150 abstracts concerning multiple myeloma have been presented, mirroring the rapid progression, and deepening of our understanding of this disease.
L. Rüsing, H. Agis, M. Krauth
semanticscholar   +1 more source

1343. Drug Education Needs of HCPs and Patients During the COVID-19 Pandemic Based on Over 60,000 Unsolicited Medical Information Requests Globally Over 3 Years (2020-2022)

Open Forum Infectious Diseases, 2023
Background The COVID-19 pandemic has resulted in 600 million cases and 6 million deaths globally since December 2019. Medical Information (MI) departments are critical during public health emergencies, providing factual, balanced and non-promotional ...
Sonia K Sandhu, Linda Chen
semanticscholar   +1 more source

Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study

British Journal of Clinical Pharmacology, Volume 92, Issue 8, Page 2723-2740, August 2026.
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga, Stefano Agliardi, Riccardo Giossi, Alice Schianchi, Alessandra Romandini, Thomas Virdis, Silvia Nerini Molteni, Maria Luisa De Angelis, Stefania Paccagnini, Cecilia Gechtman, Alice Proto, Marco Fossati, Silvia Oliveri, Giulia Angela Pattarino, Elena Altieri, Agnese Graziosi, Arianna Pani, Romano Danesi, Stefano Martinelli, Costantino De Giacomo, Francesco Scaglione   +20 more
wiley   +1 more source

2025 U.S. Geological Survey National Seismic Hazard Model for Puerto Rico and the U.S. Virgin Islands: Overview of Model and Hazard Results

Earthquake Spectra, Volume 42, Issue 2, May 2026.
The U.S. Geological Survey recently updated the National Seismic Hazard Model (NSHM) for Puerto Rico and the U.S. Virgin Islands (PRVI). The first version of the PRVI NSHM was released in 2003, and therefore this 2025 update includes over 20 years of new geologic, geophysical, and engineering data, methods, and models.
Allison M. Shumway, Kevin R. Milner, Peter M. Powers, Morgan P. Moschetti, Jason M. Altekruse, Julie A. Herrick, Andrea L. Llenos, Kyle B. Withers, Edward H. Field, Brad T. Aagaard, Richard W. Briggs, Alexandra E. Hatem, Kirstie L. Haynie, Andrew J. Michael, Jessica A. Thompson Jobe, Kishor S. Jaiswal, Brandon S. Clayton, Nicolas Luco, Mark D. Petersen, Sanaz Rezaeian, Thomas L. Pratt, Yuehua Zeng   +21 more
wiley   +1 more source

Hungary's Populist Government and the Contestation of EU Foreign Policy Co‐Operation at the United Nations: Dogs That Bark Do Not Bite?

JCMS: Journal of Common Market Studies, Volume 64, Issue 3, Page 1204-1222, May 2026.
Abstract This article provides an analysis of Hungary's role in EU foreign policy co‐operation at the United Nations General Assembly (UNGA) in the period from its accession to the EU in 2004 till 2021, which involved the shift from mainstream parties to successive governments led by the populist radical right (PRR) Fidesz party.
Carla Monteleone, Patrick Müller, Tatiana Coutto   +2 more
wiley   +1 more source

Dose–Response Association Between Handgrip Strength and All‐Cause Mortality Across Different Levels of Systemic Inflammation

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 2, April 2026.
ABSTRACT Background Longitudinal associations between C‐reactive protein (CRP) and handgrip strength from cohort studies remain inconsistent. We investigated the dose–response association between handgrip strength and all‐cause mortality across different levels of systemic inflammation.
Andrea Tur‐Boned, Lars Louis Andersen, Rubén López‐Bueno, Rodrigo Núñez‐Cortés, Carlos Cruz‐Montecinos, Luis Suso‐Martí, Ana Polo‐López, Joaquín Calatayud   +7 more
wiley   +1 more source

Comparing IPCW Models to Adjust for Informative Censoring During COVID‐19 Using Data From the Clinical Practice Research Datalink

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 10, October 2025.
ABSTRACT Purpose Observational comparative studies can be analyzed using intention‐to‐treat (ITT) (i.e., initial‐treatment) or as‐treated (AT) (i.e., per‐protocol) approaches to estimate distinct treatment effects. Unfortunately, AT analyses have an increased vulnerability to selection bias from informative censoring.
Gwen Aubrac, Michael Webster‐Clark, Robert W. Platt   +2 more
wiley   +1 more source

Effect of Protease‐Treated Royal Jelly Extract on Facial Wrinkles: A Placebo‐Controlled, Double‐Blind, Parallel‐Group Study

Journal of Cosmetic Dermatology, Volume 24, Issue 10, October 2025.
ABSTRACT Background No clinical trials have reported on the wrinkle‐improving effects of cosmetics which activate stem cells in vitro. Aims To evaluate the anti‐wrinkle effects of protease‐treated royal jelly (pRJ)‐containing cream application to the skin.
Shiho Ikegami, Takashi Ito, Hideto Okamoto, Chizuru Fujikura, Hayate Itatani, Masayuki Yagi, Akio Ohkuma, Nobuaki Okumura, Ayanori Yamaki, Norihiro Shigematsu, Kayo Kunimoto, Masatoshi Jinnin   +11 more
wiley   +1 more source

Overcoming Subaltern Silences: The Forgotten Buryat Soldiers of the Korean War

The Russian Review, Volume 84, Issue 3, Page 422-442, July 2025.
Abstract This article reassesses Soviet warfare practices by examining the use of non‐Slavic soldiers from Siberian ethnic minorities during the Korean War (1950–53). These soldiers, including Koreans, Buryats, Sakha Yakuts, and Tuvans, were deployed by the Soviet military in an elaborate deception scheme aimed at reinforcing Chinese units fighting on ...
Sayana Namsaraeva, Vitaly Tsytsykov
wiley   +1 more source